HPGCD Outperforms HPBCD as a Potential Treatment for Niemann‐Pick Disease Type C During Disease Modeling with iPS Cells

Publisher: John Wiley & Sons Inc

E-ISSN: 1549-4918|33|4|1075-1088

ISSN: 1066-5099

Source: STEM CELLS, Vol.33, Iss.4, 2015-04, pp. : 1075-1088

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content